triiodothyronine has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Misiti, S | 2 |
| Anastasi, E | 1 |
| Sciacchitano, S | 1 |
| Verga Falzacappa, C | 2 |
| Panacchia, L | 2 |
| Bucci, B | 2 |
| Khouri, D | 1 |
| D'Acquarica, I | 1 |
| Brunetti, E | 2 |
| Di Mario, U | 1 |
| Toscano, V | 2 |
| Perfetti, R | 1 |
| Michienzi, S | 1 |
| Patriarca, V | 1 |
| Stigliano, A | 1 |
2 other studies available for triiodothyronine and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
3,5,3'-Triiodo-L-thyronine enhances the differentiation of a human pancreatic duct cell line (hPANC-1) towards a beta-cell-Like phenotype.
Topics: Carcinoma, Pancreatic Ductal; Cell Differentiation; Cell Division; Cell Line, Tumor; Gene Expression | 2005 |
3,3',5-Triiodo-L-thyronine inhibits ductal pancreatic adenocarcinoma proliferation improving the cytotoxic effect of chemotherapy.
Topics: Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Pancr | 2007 |